Trial · NCT01497197
Results by group28
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 28
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Total Number of Oocytes Retrieved Per Subject Following Ovarian Stimulation | Gonal-f®+Luveris | 8.6 | Standard Deviation 6.54 | oocytes | |
| Total Number of Oocytes Retrieved Per Subject Following Ovarian Stimulation | Gonal-f® Followed by Luveris | 8.7 | Standard Deviation 5.77 | oocytes | |
| Total Number of Stimulation Treatment Days | Gonal-f®+Luveris | 11.1 | Standard Deviation 2.42 | days | |
| Total Number of Stimulation Treatment Days | Gonal-f® Followed by Luveris | 11.3 | Standard Deviation 2.24 | days | |
| Implantation Rate | Gonal-f®+Luveris | 0.5 | Standard Deviation 0.51 | fetal sacs/embryo transferred | |
| Implantation Rate | Gonal-f® Followed by Luveris | 0.4 | Standard Deviation 0.51 | fetal sacs/embryo transferred | |
| Number of Fetal Sacs With Activity | Gonal-f®+Luveris | 0.8 | Standard Deviation 0.42 | Fetal sacs | |
| Number of Fetal Sacs With Activity | Gonal-f® Followed by Luveris | 1.1 | Standard Deviation 0.54 | Fetal sacs | |
| Number of Fetal Sacs With Detectable Heart Beats | Gonal-f®+Luveris | 0.6 | Standard Deviation 0.50 | Fetal sacs | |
| Number of Fetal Sacs With Detectable Heart Beats | Gonal-f® Followed by Luveris | 1.0 | Standard Deviation 0.45 | Fetal sacs | |
| Total Pregnancy Rate and Clinical Pregnancy Rate | Gonal-f®+Luveris | Total pregnancy | 20 | percentage of subjects | |
| Total Pregnancy Rate and Clinical Pregnancy Rate | Gonal-f® Followed by Luveris | Total pregnancy | 27 | percentage of subjects | |
| Total Pregnancy Rate and Clinical Pregnancy Rate | Gonal-f®+Luveris | Clinical pregnancy | 17 | percentage of subjects | |
| Total Pregnancy Rate and Clinical Pregnancy Rate | Gonal-f® Followed by Luveris | Clinical pregnancy | 23 | percentage of subjects | |
| Cycle Cancellation Rate Prior to r-hCG | Gonal-f®+Luveris | 0 | percentage of subjects | ||
| Cycle Cancellation Rate Prior to r-hCG | Gonal-f® Followed by Luveris | 0 | percentage of subjects | ||
| Number of Subjects With Biochemical Pregnancies | Gonal-f®+Luveris | 2 | subjects | ||
| Number of Subjects With Biochemical Pregnancies | Gonal-f® Followed by Luveris | 1 | subjects | ||
| Number of Subjects With Multiple Pregnancies | Gonal-f®+Luveris | 0 | subjects | ||
| Number of Subjects With Multiple Pregnancies | Gonal-f® Followed by Luveris | 4 | subjects |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01497197/results